Accreditation for Cardiovascular Excellence (ACE) accredits academic medical center renowned as the birthplace of percutaneous coronary intervention (PCI)

Published on:

The Accreditation for Cardiovascular Excellence (ACE) is proud to announce that Emory University Hospital and Emory University Hospital Midtown, Atlanta, GA, are the latest facilities recognized with provisional accreditation by ACE. Both academic hospitals successfully completed the ACE accreditation review and succeeded in demonstrating quality in cardiovascular care

"The ACE accreditation process is a significant accomplishment in that it demonstrates a program's commitment to achieving the highest standards of care," says Bonnie Weiner, M.D., MSEC, MBA, FSCAI, FACC, and ACE's chief medical officer. "As a world leader in interventional cardiology, Emory once again serves as a model for academic medical centers aiming to better serve their patients."

Emory University has a long history of national leadership in diagnostic cardiac catheterization and interventional coronary procedures. Dr. Andreas Gruentzig, renowned for pioneering angioplasty in 1977, directed the angioplasty program at the Emory University School of Medicine from 1981 until 1985. Dr. John S. Douglas, Jr., the current director of the angioplasty program, performed the nation's first coronary stent procedure in 1987.

Today, Emory University Hospital's catheterization and interventional laboratories collectively perform more than 8,000 catheterization and interventional coronary procedures each year. By achieving ACE accreditation, Emory continues to demonstrate commitment to the highest standards of cardiovascular care and its leadership role in ongoing quality improvement.

ACE accreditation is a strategic, long-term approach based on comparing information collected against national data and best practices as defined by experts in the field of interventional cardiology. To achieve ACE accreditation, the physicians and staff at Emory University Hospital and Emory University Hospital Midtown worked hand-in-hand with ACE's expert cardiology professionals to implement appropriate use criteria, engage physicians in the quality outcomes process, and validate compliance with current published guidelines and consensus documents.

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."